Type I leprosy reaction (Q38036): Difference between revisions

From determinar.ia.br - Determine suas informações
Changed an Item
Changed an Item
 
Property / Linked ICD 10
 
Property / Linked ICD 10: A30 / rank
 
Normal rank

Latest revision as of 02:21, 13 August 2026

This phenomenon, also named “upgrading reaction,” occurs in borderline leprosy states and is associated with an increase in cell-mediated immunity. It occurs typically within the first 6 months of treatment in previously untreated patients but may be related to stress, intercurrent infections, or pregnancy. Clinical features include inflammatory swelling, erythema and occasionally ulceration of existing lesions, constitutional symptoms and neuritis. If the neuritis is not treated promptly permanent motor nerve damage may ensue.
Language Label Description Also known as
default for all languages
1B20.20
    English
    Type I leprosy reaction
    This phenomenon, also named “upgrading reaction,” occurs in borderline leprosy states and is associated with an increase in cell-mediated immunity. It occurs typically within the first 6 months of treatment in previously untreated patients but may be related to stress, intercurrent infections, or pregnancy. Clinical features include inflammatory swelling, erythema and occasionally ulceration of existing lesions, constitutional symptoms and neuritis. If the neuritis is not treated promptly permanent motor nerve damage may ensue.

      Statements

      CID11:1B20.20
      0 references
      dki-india-1B20.20
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references